L-Carnitine Oral Solution single dose 1g/10ml

Therapeutic indications

Levocarnitine Oral Solution single dose 1g/10ml is indicated for the treatment of primary and secondary carnitine deficiency in children of under 12 years, infants and newborns. 
L-carnitine belongs to the substances that act in the body for the smooth progression of normal body functions mainly through metabolism, it has a vitamin-specific effect.
L-carnitine is the only vehicle that uses long chain fatty acids to cross the mitochondrial membrane.
• It controls the transfer of the energy produced in the mitochondria to the cytoplasm, particularly in the skeletal muscle and myocardium.

• Proven effectiveness with Clinical Phase IIΙB Study:

"L-carnitine co-administration with simvastatin reduces levels of lipoprotein (a)"
A double-blind, randomized, placebo-controlled, multicenter study

Lyberopoulos E. et al (2016)1

Available in packages of 10 vials